Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lansoprazole vs Gefarnate for Prevention of Ulcer Recurrence in Low-Dose Aspirin Users
NCT00762359Phase 3Terminated
- Sponsor
- Takeda
- Start
- May 2007
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lansoprazole in gastric ulcer, duodenal ulcer, sponsored by Takeda. Started May 2007; status: terminated.
02
Drugs
lansoprazole
03
Conditions
gastric ulcerduodenal ulcer
Beyond the preview
Go deeper on NCT00762359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00762359.